Tetraphase Pharmaceuticals (TTPH)

Trade TTPH now with
2/27/2018 8:15:35 AM Tetraphase Reports FDA Acceptance For Filing Of NDA Submission For Eravacycline
2/13/2018 4:06:35 PM Tetraphase Pharmaceuticals Trading Halted; Expected To Resume At 4:30 PM ET
11/2/2017 8:15:08 AM Tetraphase Pharma Q3 Net Loss $30.0 Mln Or $0.63/shr Vs Loss Of $21.1 Mln Or $0.58/Shr Last Year
10/16/2017 9:04:30 AM Tetraphase Appoints Kamalam Unninayar As CFO
8/17/2017 8:33:27 AM Tetraphase Announces Submission And Validation Of IV Eravacycline Marketing Authorization Application By EMA
4/3/2017 8:04:38 AM Tetraphase Pharma Completes Enrollment Of IGNITE4 Phase 3 Clinical Trial Of Eravacycline